Pfizer In Talks To Buy Wyeth In $60 Billion Deal
NEW YORK - Pfizer Inc. is in talks to acquire rival drug maker Wyeth in a deal that could be valued at more than $60 billion, said people familiar with the matter told the Wall Street Journal. A combination of these two U.S. pharmaceutical giants would redraw the boundaries of the global drug industry, which